Skip to main content
CND In the News

CND Life Sciences CEO Rick Morello Discusses Syn-One Test™ on the Price of Business Radio Show

By November 16, 2020August 12th, 2024No Comments

CND Life Sciences CEO Rick Morello Discusses Syn-One Test™ on the Price of Business Radio Show  

Rick Morello spoke with Kevin Price, host of the Price of Business Radio Show, about how the Syn-One Test™ is advancing the way that neurodegenerative diseases like Parkinson’s disease and dementia with Lewy bodies are diagnosed.   

LISTEN TO THE INTERVIEW
CND Life Sciences

CND Life Sciences is the creator of the Syn-One Test, the world’s first commercially available test to visualize phosphorylated alpha-synuclein in cutaneous nerve fibers. The test is an objective, evidence-based diagnostic tool to aid in the diagnosis of Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, or pure autonomic failure.